These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6459990)

  • 1. beta 1H stimulates mouse-spleen B lymphocytes as demonstrated by increased thymidine incorporation and formation of B cell blasts.
    Hammann KP; Raile A; Schmitt M; Mussel HH; Peters H; Scheiner O; Dierich MP
    Immunobiology; 1981; 160(3-4):289-301. PubMed ID: 6459990
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
    Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    Lambris JD; Dobson NJ; Ross GD
    J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Fc receptor mediated functions by split products of C3.
    Gergely J; Erdei A; Fábry Z
    Mol Immunol; 1984 Dec; 21(12):1205-10. PubMed ID: 6240595
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement components on human lymphocytes.
    Wilson AB; Prichard-Thomas S; Gurner BW; Lachmann PJ; Coombs RR
    Clin Immunol Immunopathol; 1982 Jan; 22(1):118-27. PubMed ID: 6214346
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T; Lavoie S; Nussenzweig V
    J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the binding of C3-coated particles to human lymphocytes by human complement component H.
    Fontaine M; Daveau M; Gilbert D
    Scand J Immunol; 1983 May; 17(5):463-70. PubMed ID: 6222471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells with or without C3 receptor:murine B-cell subsets highly and lowly responsive to anti-ig stimulation.
    Nariuchi H; Kakiuchi T
    Cell Immunol; 1980 Nov; 56(1):184-92. PubMed ID: 6968638
    [No Abstract]   [Full Text] [Related]  

  • 9. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of factor I mediated cleavage of the third component of complement.
    Davis AE; Harrison RA
    Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes.
    Erdei A; Füst G; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1977 Nov; 8(3):367-76. PubMed ID: 334400
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of complement receptors.
    Dierich MP; Scheiner O; Mussel HH; Hamman KP; Schopf RE; Schulz T
    Mol Immunol; 1982 Oct; 19(10):1255-65. PubMed ID: 6217417
    [No Abstract]   [Full Text] [Related]  

  • 13. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b.
    Reiter Y; Fishelson Z
    J Immunol; 1989 Apr; 142(8):2771-7. PubMed ID: 2522969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):427-34. PubMed ID: 2935338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    Fearon DT
    J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3b inactivator and beta 1H.
    Crossley LG
    Methods Enzymol; 1981; 80 Pt C():112-24. PubMed ID: 6210825
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.